JD Health International (HKSE:06618) 3-Year Revenue Growth Rate : 21.20% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is JD Health International 3-Year Revenue Growth Rate?

JD Health International's Revenue per Share for the six months ended in Dec. 2023 was HK$9.13.

During the past 12 months, JD Health International's average Revenue per Share Growth Rate was 11.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 21.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 47.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of JD Health International was 70.40% per year. The lowest was 21.20% per year. And the median was 61.25% per year.

Competitive Comparison of JD Health International's 3-Year Revenue Growth Rate

For the Medical Care Facilities subindustry, JD Health International's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

JD Health International's 3-Year Revenue Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, JD Health International's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where JD Health International's 3-Year Revenue Growth Rate falls into.

JD Health International 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

JD Health International (HKSE:06618) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

JD Health International 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of JD Health International's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

JD Health International (HKSE:06618) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » JD Health International Inc (HKSE:06618) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

JDHIY:USA JDHIF:USA 8ZN:Germany

Address

No. 20 Kechuang 11 Street, Block C, Building 2, Jingdong Headquarters, Economic and Technological Development Zone, Daxing District, Beijing, CHN, 101111

Website

https://ir.jdhealth.com

JD Health is the largest healthcare e-commerce platform in China in terms of revenue. The company offers pharmaceutical drugs and healthcare products on its platform, both as a marketplace that connects merchants to consumers and as a first-party, or 1P, direct retailer. It also offers online consultation from real life doctors and separately partners with offline pharmacies that can provide location-based 24/7 delivery as part of an omnichannel initiative to complement its core e-commerce business. Its closest competitors are Alibaba Health, Ping An Good Doctor, and Meituan for its e-commerce business. As of Dec. 31, 2022, the platform has 154.3 million active annual users and over 70,000 merchants. JD Health is 67.49% owned by its parent company, JD.com.

JD Health International (HKSE:06618) Headlines

No Headlines